This inventor holds 11 USPTO granted patents. Top assignees: Societe D'etude Et De Recherche En Ingenierie Pharmaceutique Seripharm, Stragen Pharma Sa, Oncopharm Corporation. Active years: 2001-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pruillé le Chétif, FR (2003)
- Pruille le Chetif, FR (2003 - 2007)
- Le Mans, FR (2001 - 2008)
Company Filing History:
5 out of 5 
3 out of 6 
2 out of 2 
Years Active: 2001-2008
Title: The Innovative Contributions of Robert Dhal
Introduction
Robert Dhal is a prominent inventor based in Le Mans, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 11 patents to his name, Dhal's work has had a considerable impact on medical research and therapeutic applications.
Latest Patents
Among his latest patents, Dhal has developed intermediates for the hemisynthesis of taxanes and preparation processes therefor. This invention relates to precursor compounds and derivatives that facilitate the preparation of taxanes and baccatin derivatives. Another notable patent involves cephalotaxanes, which includes methods of preparation and their use in treating cancers, leukemias, and parasites, including those resistant to conventional chemotherapeutic agents.
Career Highlights
Throughout his career, Robert Dhal has worked with several notable companies in the pharmaceutical industry. He has been associated with Société d'Étude et de Recherche en Ingénierie Pharmaceutique Seripharm and Stragen Pharma SA. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Dhal has collaborated with esteemed colleagues such as Jean-Pierre Robin and Luc Chanteloup. These partnerships have fostered innovation and have been instrumental in the successful development of his patented technologies.
Conclusion
Robert Dhal's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of cancer treatment. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile